DOCSLIB.ORG

Download a Pdf Version of the 2017 Convention Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download a Pdf Version of the 2017 Convention Program 2017 ANNUAL CONVENTION 6&7 December Hotel Realm 18 National Circuit, Barton, ACT AAMRI MEMBERS EVENT CONTACTS Peter Thomas, 0411 600 992, [email protected] Kathryn Naumenko, 0402 117 529, [email protected] Cath Latham, 0413 865 459, [email protected] 2 CONVENTION PROGRAM WED 6 DEC 9.00am REGISTRATION OPENS 9.30am-12.30pm MRI BUSINESS MANAGERS’ MEETING Pages 7-14 National Ballroom 2, Hotel Realm Canberra 12.30pm-1.30pm LUNCH National Ballroom 1, Hotel Realm Canberra 1.30pm-5.00pm AAMRI STRATEGY MEETING Pages 15-22 National Ballroom 2, Hotel Realm Canberra 5.30pm-6.30pm MRI BOARD MEMBER PRE-DINNER DRINKS High Courtyard South, Hotel Realm Canberra 6.30pm COURTESY BUSES FROM HOTEL REALM TO PARLIAMENT HOUSE Depart from the rear of Hotel Realm, in Burbury Close 7.00pm 2017 AAMRI ANNUAL DINNER Great Hall, Parliament House Guest speaker: The Hon Greg Hunt MP, Minister for Health, Minister for Sport 10.15PM Courtesy bus from Parliament House to Hotel Realm Canberra THURS 7 DEC 7.30am-8.30am AAMRI PRESIDENT’S BREAKFAST National Ballroom 2, Hotel Realm Canberra Guest speaker: The Hon Bill Shorten MP, Leader of the Opposition 8.45am-11.00am AAMRI AGM (REGISTRATION FROM 8.30AM) Pages 23-27 National Ballroom 2, Hotel Realm Canberra 3 PARTICIPANTS Mr Peter Allen Board Chair Wesley Medical Research Ms Gina Anderson Board Member The George Institute for Global Health Mr Richard Balderstone Board Olivia Newton-John Cancer Research Institute Dr Johanna Barclay Research Development Manager Mater Medical Research Institute Mr Mark Bizeray CFO Children's Cancer Institute Mr David Blair COO Menzies School of Health Research Ms Hilary Bolton Executive General Manager, Baker Heart & Diabetes Institute Operations Mr Ian Briggs Chief Technology Officer Baker Institute, Burnet Institute, CERA Mr Matthew Browne CFO & Company Secretary Melanoma Institute Australia Ms Lee Bruce Director Corporate Services Translational Research Institute Ms Anna Burke Board Director Institute for Breathing and Sleep Ms Lee Byrne Projects and Communications Walter and Eliza Hall Institute of Medical Specialist Research Prof Jonathan Carapetis Director Telethon Kids Institute Prof John Carroll Director/Dean Monash Biomedicine Discovery Institute Mr Joseph Carrozzi Partner PwC Prof Helen Christensen Chief Scientist and Director Black Dog Institute A/Prof Stella Clark Board Member Bionics Institute Ms Nicole Cockayne Director Discovery and Innovation Black Dog Institute Mr Matt Cousins Manager John Curtin School of Medical Research Prof Brendan Crabb AC CEO Burnet Institute Mr Michael Creevey Acting CEO - endpointIQ QIMR Berghofer Medical Research Institute Mr Malcolm Crompton AM Chair PRAXIS Australia Prof Tony Cunningham AO President AAMRI Prof Peter Currie Director Australian Regenerative Medicine Institute Mr John Dakin COO Westmead Institute for Medical Research Ms Joanne Darmanin Associate Director - IT Orygen, The National Centre of Excellence in Youth Mental Health Mr Russell D'Costa Operations Manager Centre for Cancer Biology Dr Henry De Aizpurua Deputy Director The Florey Institute of Neuroscience and Mental Health Dr Nicole den Elzen Executive General Manager, Baker Heart & Diabetes Institute Research Management & Strategy Mr Andrew Dermott Finance Manager Neuroscience Research Australia Prof Geoffrey Donnan AO Director The Florey Institute of Neuroscience and Mental Health Mr Brendon Douglas Director of Research Menzies School of Health Research A/Prof Briony Dow Director National Ageing Research Institute Dr James Dromey COO Murdoch Children's Research Institute Dr. Bob Edgar Board Chair Hudson Institute of Medical Research Mrs Joanne Elliot COO Woolcock Institute of Medical Research Mr Gerald Ewing CEO Regis Mutual Management Dr Alan Finkel AO Australian Chief Scientist Office of the Chief Scientist Prof Simon Foote Director John Curtin School of Medical Research Mr Peter Forbes Chair Lions Eye Institute Mrs Carolyn Forster OAM Board Vice President Children's Medical Research Institute Prof Ian Frazer AC President Australian Academy of Health and Medical Sciences Prof Frank Gannon Director and CEO QIMR Berghofer Medical Research Institute Mrs Melanie Gentgall CEO PRAXIS Australia 4 Dr Parisa Glass Director of Operations The George Institute for Global Health Mr Marcus Goddard Business Manager Robinson Research Institute Mr Peter Gover COO Bionics Institute Prof Michelle Haber AM Executive Director Children's Cancer Institute Mr Darryl Harkness CEO Ingham Institute for Applied Medical Research Prof Elizabeth Hartland Director and CEO Hudson Institute of Medical Research Dr Andy Hastings Manager, VicAAMRI AAMRI Prof Doug Hilton AO Director Walter and Eliza Hall Institute of Medical Research Dr Stephen Hollings CEO Heart Research Institute Mr Larry Iffla Chair Harry Perkins Institute of Medical Research Ms Janina Jancu COO Victor Chang Cardiac Research Institute Dr Anne Johnston Head, Research Strategy St Vincent's Institute of Medical Research Dr Kate Johnston COO Neuroscience Research Australia Mr Peter Joseph Chair Black Dog Institute Prof Thomas Kay Director St Vincent's Institute of Medical Research Prof Anne Kelso AO Chief Executive Officer National Health and Medical Research Council Dr Maree Knight Deputy Director Operations Mater Medical Research Institute Prof Sharad Kumar Co-Director Centre for Cancer Biology Dr Cath Latham Policy & Project Officer AAMRI Mrs Lien Le Deputy Director RDS/Nectar/ANDS Prof Peter Leedman Director Harry Perkins Institute of Medical Research Mrs Kate LeMay Senior Research Data Specialist Australian National Data Service Mr David Lloyd Deputy Director/COO Baker Heart & Diabetes Institute Mr Kyle Loades Chair Hunter Medical Research Institute Prof Angel Lopez AO Co-Director Centre for Cancer Biology Miss Samantha Ludolf Deputy Director, Strategy & Walter and Eliza Hall Institute of Medical Operations Research Mrs Jacinta Mackey Chief Operating & Financial Officer Centre for Eye Research Australia Prof David Mackey Managing Director Lions Eye Institute Ms Sue MacLeman CEO & Managing Director MTPConnect Prof Frank Martin AM Chair Children’s Medical Research Institute Dr Alfredo Martinez-Coll General Manager, Stakeholder MTPConnect Engagement Mr Rory McQuillan COO Monash Biomedicine Discovery Institute Mr Rob Merriel CFO Hudson Institute of Medical Research Mr Andrew Mir CFO Brien Holden Vision Institute Mr Ralph Mitchell COO Children's Medical Research Institute Prof Maxine Morand Chair, Board of Directors Peter MacCallum Cancer Centre Mr Ian Mundy Member Services Director Unimutual Ms Kathryn Naumenko Events & Administration Assistant AAMRI Prof Kathryn North AM Director Murdoch Children's Research Institute Ms Debra O'Connor Deputy Director National Ageing Research Institute A/Prof Peter O'Loughlin Acting Head Hanson Institute Dr Nick Pearce COO Centenary Institute Prof Vlado Perkovic Executive Director The George Institute for Global Health Prof Karlheinz Peter Deputy Director Baker Heart & Diabetes Institute Prof Mark Radford CEO Queensland Eye Institute 5 PARTICIPANTS Prof Roger Reddel Director Children's Medical Research Institute Mr Tim Regan COO The George Institute for Global Health Mr Jon Rhoades IT Manager St Vincent's Institute of Medical Research Prof Sarah Robertson Director Robinson Research Institute Ms Kelly Rodger VIP AAMRI Mr Tobias Schoep Senior Research Development Telethon Kids Institute Officer Prof Peter Schofield Executive Director & CEO Neuroscience Research Australia Mr Peter Scott Deputy Chair Gresham Ms Brenda Shanahan Board Chair St Vincent's Institute of Medical Research Mr Mark Sheridan Chair Queensland Eye Institute Prof Carolyn Sue Director Kolling Institute Mrs Julie Taranto Research Operations ANZAC Research Institute Manager/RAO Mr Mark Tennent COO Burnet Institute Mr Chris Thomas Chair Walter and Eliza Hall Institute of Medical Research Dr Peter Thomas Director of Policy and Operations AAMRI Dr Anne Thorburn Head of Operations, St Vincent's Institute of Medical Research Administration Prof Joseph A. Trapani Executive Director Cancer Peter MacCallum Cancer Centre Research Ms Kim Tsai COO / CFO Olivia Newton-John Cancer Research Institute Prof Mathew Vadas AO Director Centenary Institute Prof Alison Venn Director Menzies Institute for Medical Research Mr Paul Watt Director of Research Services and Telethon Kids Institute Innovation Mr Rod Wealands COO Hudson Institute of Medical Research Dr Peter Wejbora Head of Research Development & Children's Cancer Institute Partnerships Prof Steve Wesselingh Executive Director South Australian Health and Medical Research Institute Mr Chris Whitelock COO Lions Eye Institute Prof Stephen Wood Associate Director, Research Orygen, The National Centre of Excellence in Youth Mental Health Mr Nicholas Wood Director of Corporate Services Telethon Kids Institute 6 MRI BUSINESS MANAGERS’ MEETING WEDNESDAY 6 DECEMBER, 9.00AM – 12.30PM National Ballroom 2, Hotel Realm Canberra Chair: Dr Cath Latham, Policy & Project Officer, AAMRI 9.00am REGISTRATION OPENS 9.30am WELCOME Session Chair: Dr Cath Latham, AAMRI 9.35am-10.25am OPPORTUNITIES FOR MRIS: NATIONAL FACILITIES FOR RESEARCH DATA MANAGEMENT 9.35am MRIs and Data Sharing Ms Kate LeMay, Senior Research Data Specialist, Australian National Data Service (ANDS) 9.50am Opportunities for MRIs at RDS and Nectar Dr Lien Le, Deputy Director, Research Data Services (RDS) 10.05am Connecting Colorectal cancer data and making it FAIR Professor Steve Wesselingh, Executive Director, South Australian
Load more

Recommended publications
  • Telethon Kids Institute Has a Strong Track Record in Research, Evaluation and Implementation Related to Improving Child Development Outcomes in the Early Years
    22 May 2016 Commissioners Jonathan Coppel and Julie Abramson National Education Evidence Base Productivity Commission Locked Bag 2, Collins St East PO Melbourne VIC 8003 Dear Commissioners The Telethon Kids Institute has a strong track record in research, evaluation and implementation related to improving child development outcomes in the early years. It was a key partner in the adaption and piloting of the Early Development Index in Australia, and its subsequent national dissemination as the Australian Early Development Census. Through its WA Child Health Survey and the seminal WA Aboriginal Child Health Survey, the Telethon Kids Institute has provided the evidence and recommendations for many child health initiatives. It also has a proud history of advocacy, having lobbied for services through education and health, contributing to the various models of family, child and parent centres and visiting midwife schemes. In addition, the Telethon Kids Institute, in partnership with 14 State government agencies, has set up one of the largest linked data capabilities in Australia, and arguably, the world. This capacity links data from the majority of the health, education and social service agencies in WA, to enable research, monitoring and evaluation of children’s outcomes across a number of domains (i.e. health, education, child maltreatment, mental health, disability, justice and housing). Some data were collected in the 1960s, with the majority collected since 1980 for individuals born in WA. The Telethon Kids Institute has always worked closely with community and service providers to both frame the research approach and translate research findings into policy and practice. This approach is entrenched in the Institute's strategic plan: Working Together 2013-2017 and described in a number of programs in its IMPACT report.
    [Show full text]
  • Seizure Dynamics
    Balson et al. BMC Neuroscience 2014, 15(Suppl 1):P152 http://www.biomedcentral.com/1471-2202/15/S1/P152 POSTERPRESENTATION Open Access Seizure dynamics: a computational model based approach demonstrating variability in seizure mechanisms Richard S Balson1,2,3,4*, Dean R Freestone1,2,3, Mark J Cook2,3, Anthony N Burkitt1,2,4, David B Grayden1,2,4 From The Twenty Third Annual Computational Neuroscience Meeting: CNS*2014 Québec City, Canada. 26-31 July 2014 Epilepsy is a neurological disorder that affects approxi- animals, based upon recorded LFP 150 seconds prior to mately 1% of the world’s population. At present, the and post seizure, as well as during the seizure. The esti- underlying mechanisms involved in seizure generation mation results show that, for three of the four animals, and termination are not fully understood. A computa- the mechanisms involved in their seizures are similar. tional model-based approach to provide further insights For the fourth animal, the estimated physiology prior to, into physiological changes occurring in the brain prior during, and post seizure vary drastically. When compar- to, during, and post seizure is presented. We demon- ing the physiological dynamics between animals, we strate that an unscented Kalman filter [1] can be used found that the estimation results predicted that there to fit physiological parameters of a neural mass model are different mechanisms involved in seizure initiation, [2] to recorded EEG. This technique elucidates physiolo- evolution, and termination in each animal. The common gical changes in recorded EEG that cannot be deter- element in all the results, except for a single estimated mined with standard EEG analysis methods.
    [Show full text]
  • 2007 Annual Report Annual Institute Eye Lions Review Molecular
    Lions Eye Institute ABN 48 106 521 439 2 Verdun Street, Nedlands WA 6009 General Administration & Research Enquiries 9381 0777 Administration & Research Facsimile 9381 0700 07 International +61 8 9381 0777 Clinical Facilities Elsie Gadd Eye Clinic Appointments 9381 0888 Day Surgery Facility 9381 0880 Laser Vision Centre 9381 0758 Clinical Facilities Facsimile 9382 1171 Annual REPORT 20 WWW.LEI.ORG.AU RAZOREYE LEI5693 02/08 Lions Eye Institute 2007 Annual Report Annual Report 2007 Corporate Directory Mission Lions Eye Institute Prof. Ian Constable AO Assoc. Prof. Geoffrey Crawford Administration & Finance Our mission is to achieve excellence Managing Director Director of Surgical Services [email protected] [email protected] Chee-Peng Yao in scientific research and clinical practice 9381 0871 Chief Financial Officer Esther McCloskey [email protected] to prevent blindness. Executive Assistant to Prof. Constable Assoc. Prof. Graham Barrett 9381 0703 [email protected] [email protected] 9381 0882 9381 0872 David Eiszele Dr Jean-Louis deSousa Information Technology Chairman [email protected] & Communications 9381 0777 9381 0747 Yaasin Lutta Dr Adam Gajdatsy Head of Information Technology [email protected] & Communications Research 9381 0763 [email protected] 9381 0786 Prof. P. Elizabeth Rakoczy Dr Antonio Giubilato Director of Research; [email protected] Director, Molecular Ophthalmology 9381 0819 [email protected] Lions Eye Bank 9381 0726 Dr Tim Isaacs [email protected] Stephanie Durham Coordinator Assoc. Prof. Mariapia Degli-Esposti 9381 0862 Co-Director, Centre for Experimental [email protected] Immunology; Assoc.
    [Show full text]
  • Snapgrant™ - DO NOT DISTRIBUTE
    6/20/2019 Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma ™ SnapGrant - DO NOT DISTRIBUTE TELETHON KIDS INSTITUTE Terrance Johns [email protected] 61402490131 Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands Perth, Western Australia 6009 Australia DEVELOPMENT OF A NEW AND EFFECTIVE THERAPY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA Translational DIPG, Childhood (Brain Cancer) Afliation: Cure Fund Requested Funding: $49,512 EXECUTIVE SUMMARY https://snapgrant.com/grant/view?id=223 1/4 6/20/2019 Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma Background- Cancer currently stands as one of the leading causes of death worldwide, killing nearly 10 million people in 2018. Among the different forms of cancer, those affecting the brain and Central Nervous Systems are among the deadliest and most difcult to treat. According to gures from the World Health Organization, in 2018 over 70% of all patients diagnosed with brain cancer died in the United Stated, and over 80% in Australia. Despite these troubling gures, no signicant improvement in high grade brain cancer treatment has been made over the past 30 years. This situation is worsened by a notable lack of funding for brain cancer research, particular in children. In Australia, for example, the 2017-2018 federal funding from the National Health and Medical Research Council (NHMRC) for children brain cancer represented only 0.36% of the total NHMRC research budget for that time period. Among childhood brain cancers, Diffuse intrinsic pontine glioma (DIPG) is the most difcult to treat: more than 99% of all DIPG patients will die, due to a lack of effective treatments.
    [Show full text]
  • Menzies School of Health Research
    MENZIES SCHOOL OF HEALTH RESEARCH 2020-21 Pre-Budget Submission September 2020 Contact: Professor Alan Cass Director, Menzies School of Health Research Ph: 08 8946 8600 Email: [email protected] Web: www.menzies.edu.au ABN: 70 413 542 847 Menzies School of Health Research (Menzies) is pleased to put forward its 2020-21 Pre-Budget submission. 1. Summary of recommendations The medical and health research sector has an important role in supporting economic growth, job creation and attracting investment to Australia. This role has been further emphasised in key policy statements from both the Northern Territory and Commonwealth Governments to ensure the future prosperity of northern Australia. For example, medical and health research is a stated economic priority in the Northern Territory Economic Development Framework and its Economic Reconstruction Priorities, as well as being highlighted as a strategic priority in the Commonwealth’s White Paper on Developing Northern Australia. Directly related to supporting medical and health research in northern Australia, this pre-budget submission requests that the Commonwealth provide $5m to support a four (4) year extension to the Northern Australia Tropical Disease Collaborative Research Program (NATDCRP), administered by Menzies School of Health Research in collaboration with seven (7) of Australia’s leading health research organisations – James Cook University, Telethon Kids Institute, Burnet Institute, The University of Sydney, the South Australian Health and Medical Research Institute, Doherty Institute and QIMR Berghofer Medical Research Institute. The NATDCRP – now referred to as the HOT North Program - was announced as a $6.8m budget measure by the Minister for Trade and Investment, the Hon Andrew Robb on 10 May 2015.
    [Show full text]
  • Finding Cures for Cardiovascular Disease Through World-Class Medical Research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03
    IMPACT REPORT 2019 Finding cures for cardiovascular disease through world-class medical research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03 For years the Victor Chang Cardiac Research Institute has Contents been Australia’s home of heart research. Since , the Institute has made an unshakeable contribution to the fight against About Us 4 Heart Disease Statistics 6 cardiovascular disease, and that PATIENT STORY SCAD Survivor 8 makes us overwhelmingly proud. Chairman’s Report 10 Executive Director’s Report 14 In ­­ we farewell our PATIENT STORY Cardiac Arrest Survivor 16 Organisational Structure 17 pioneering Executive Director, Board of Directors 18 Professor Bob Graham. 25 years of discovery 20 PROFILE Professor Bob Graham 24 Nevertheless, we are confident PROFILE Professor Diane Fatkin 34 that in Professor Jason Kovacic PROFILE Professor Livia Hool 38 Research Divisions Overview 42 we have a champion who will not Victor Chang Cardiac Research Institute Innovation Centre 44 only continue this legacy but take Sohn Hearts & Minds the Institute to the next level, as Investment Leaders Conference 46 Heart Health Checks 48 the new leader of the organisation. Statement of Income and Expenditure 49 Achievements and Awards 50 Fundraising Events 52 Supporters and Acknowledgments 54 This special 25th Anniversary edition is dedicated Support Life-Saving Heart Research 57 to you, our loyal supporters. After a quarter of a century, thanks to you, we’re only just getting started. Here’s to another 25 illustrious years! 04 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 05 About Us Our Mission Our Statistics Australia’s home The relief of pain and suffering and the promotion of wellbeing, of heart research through an understanding of the fundamental The Victor Chang Cardiac Research mechanisms of researchers and staff cardiovascular biology in Institute is dedicated to finding cures health and disease.
    [Show full text]
  • Improving Outcomes of Deep Brain Stimulation for Essential Tremor with Motion Tracking and Speech Analysis
    IETF Grant Proposal: 27 February 2015 Improving Outcomes of Deep Brain Stimulation for Essential Tremor with Motion Tracking and Speech Analysis Brief Summary Deep Brain Stimulation (DBS) is a common form of treatment for medically refractory essential tremor (ET). DBS consists of one or two small electrode arrays that are placed in specific brain targets by a trained neurosurgeon. Controlled electrical pulses are then sent to these electrodes by a neuro- stimulator to modify brain activity and provide therapeutic benefit. The characteristics (duration, amplitude, and frequency) of these pulses must be set to minimize tremor, yet prevent unwanted side- effects such as speech difficulties. Usually, these parameters are set by a neurologist based on their observation of tremor and side-effect. In general, the ventral intermediate nucleus (VIM) of the brain is considered the most appropriate target for stimulation. Recently, however, the posterior subthalamic area (PSA) was also discovered to be an effective stimulation target. Since this discovery, much debate has ensued regarding which is the better target in terms of tremor and side-effect reduction. For each target, the stimulation level must also be considered due to influence on implant battery life. In this study we aim to determine which of the two targets provides the best outcome to the patient using novel methods to quantify tremor and side- effect. The majority of clinical assessments of ET rely on clinical scores based on observation. These are subjective measures influenced by the clinician’s opinion and experience. Unfortunately, the accuracy and sensitivity of such measures can be inadequate. To improve assessment of ET, we have developed our own method of tremor measurement based on electronic motion tracking.
    [Show full text]
  • Minderoo Foundation's $5 Million Donation to Zero
    MINDEROO FOUNDATION’S $5 MILLION DONATION TO ZERO CHILDHOOD CANCER WILL HELP KIDS LIKE JACK BEAT BRAIN CANCER Two years ago, Jack Burai was diagnosed with a low-grade cancer in the brain (glioma) at just 9 years old. Following surgery his prognosis was good and his parents, Vivian and Alex believed Jack to be cured. 12 months later Jack relapsed and was in hospital with multiple tumours in his brain and spine, his cancer failed to respond to standard treatment and his condition was rapidly declining. His eyesight was threatened by the build-up of fluid in his brain and he could no longer walk. Jack was enrolled in the Zero Childhood Cancer program (Zero), which genetically tested Jack’s cancer, and detected a BRAF V600E mutation that was believed to be driving the aggressive growth of his cancer. The team identified new therapies uniquely designed to target and kill his tumours. Within 45 days Jack was out of a wheelchair, playing tennis, and today Jack is back at school and doing well. Today (15 May) Minderoo Foundation’s Eliminate Cancer initiative will announce a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols. Australian philanthropists Andrew and Nicola Forrest founded Minderoo Foundation in 2001 and, since then, have committed over $1.5 billion to the Foundation and its partners to address some of the world’s most urgent and complex challenges, including the fight against cancer which Minderoo has committed $75 million to through its Eliminate Cancer initiative.
    [Show full text]
  • Melbourne Biomedical Precinct Studley Rd to an Exceptional Network Economic and Investment Growth Swinburne University of of Skilled Workers, Quality for the State
    The Royal Children’s Hospital + The Murdoch Children’s Research Institute The Royal Women’s Hospital Darwin Walter & Eliza Hall Institute Monash Institute of Pharmaceutical NT Science, Monash University + CSIRO QLD Royal Melbourne Hospital WA Brisbane C Florey Institute SA e m ete ry Rd The University of Melbourne NSW Perth Sydney A Precinct approach Victorian Comprehensive Cancer Centre Adelaide Royal Pde Canberra + Peter MacCallum Cancer Centre The Doherty Institute to collaboration Flemington Rd Elgin St St Vincent’s Hospital Melbourne Hobart Melbourne, Grattan St Swanston St Australia and innovation Arden St Curzon St Elizabeth St Lygon St La Trobe University Queensberry St d R g r e b Burgundy St Rathdowne St l Chetwynd St Victoria St e > id e Melbourne Brain Centre H r Peel St e Austin Health p Plan Melbourne, Victoria’s key metropolitan Franklin St p Melbourne has biomedical La Trobe St U Austin Hospital planning strategy, highlights the precincts Banksia St capabilities unparalleled in around Melbourne, Monash, Deakin, Olivia Newton-John Australia and amongst the and La Trobe universities as clusters CSL Cancer Wellness & world’s best. We are home which offer significant opportunities (Poplar Road) Research Centre for innovation as well as employment, Melbourne Biomedical Precinct Studley Rd to an exceptional network economic and investment growth Swinburne University of of skilled workers, quality for the state. Technology education providers, leading The Melbourne Biomedical Precinct Deakin University St Kilda Rd research institutes and a Partners are largely collocated to the Princes Hwy Commercial Rd Burwood & Geelong Campuses sophisticated health system. north of Melbourne’s CBD close to Monash University, Australia’s highest ranking university, Clayton � Caulfield There is a growing body of evidence the University of Melbourne.
    [Show full text]
  • Today's Research Tomorrow's Cure
    2018 Heart Research Institute Annual Review Accelerating Research Tomorrow’s cure Tomorrow’s Today’s research Today’s 2018 Heart Research Institute Annual Review Hello Future Accelerating 2018 Heart Research Institute Annual Review Research ACCELERATING Discoveries into therapies Knowledge into prevention Breakthroughs into cures Students into leaders Collaborations into partnerships 4 2018 Heart Research Institute Annual Review Inspiring Leaders 2018 Heart Research Institute Annual Review CONTENTS 06 HRI in 2018 08 Chairman’s Report 2018 10 Director of Cardiovascular Research Report 12 2018 Research and Media Highlights 16 Applied Materials Group 18 Atherosclerosis and Vascular Remodelling Group 20 Cardiac Imaging Group 22 Cardiometabolic Disease Group 24 Cardiovascular Medical Devices Group 26 Cell Therapeutics Group 28 Clinical Research Group 30 Haematology Research Group 32 Heart Rhythm and Stroke Prevention Group 34 High Blood Pressure Group 36 Thrombosis Group 38 Vascular Complications Group 40 Vascular Immunology Group 42 Inflammation and Fibrosis Research 44 PhD Students 45 Select Prizes and Awards 46 Select Conferences and Presentations 50 Select Publications 56 Board of Governors 59 International Board of Governors 60 Members of the Institute 62 Fundraising Report 66 Operations Report 6 2018 Heart Research Institute Annual Review The mission of the Heart Research Institute (HRI) is to prevent death and suffering from cardiovascular disease through an understanding of the biological processes that cause atherosclerosis and thrombosis, the major underlying causes of most heart attacks and strokes. 20 18 SHORT TERM LONG TERM The major short-term focus of our research There are four long-term objectives is to understand the development and for our research: progression of atherothrombotic conditions • To investigate mechanisms in which the arteries are narrowed and contributing to the pathogenesis restricted due to a build-up of fatty of cardiovascular disease.
    [Show full text]
  • 2010-2011 Annual Report
    Annual Report 2010-2011 Mastery of disease through discovery | www.wehi.edu.au Contents 1 About the institute 3 Director’s and Chairman’s report 5 Discovery 8 Cancer and Haematology 10 Stem Cells and Cancer 12 Molecular Genetics of Cancer 14 Chemical Biology 16 Molecular Medicine 18 Structural Biology 20 Bioinformatics 22 Infection and Immunity 24 Immunology The Walter and Eliza Hall Institute 26 Autoimmunity and Transplantation of Medical Research 28 Cell Signalling and Cell Death 1G Royal Parade 30 Inflammation Parkville Victoria 3052 Australia Telephone: (+61 3) 9345 2555 32 Molecular Immunology Facsimile: (+61 3) 9347 0852 34 Publications WEHI Biotechnology Centre 36 Awards 4 Research Avenue 37 Translation La Trobe R&D Park Bundoora Victoria 3086 Australia Translating our research 38 Telephone: (+61 3) 9345 2200 40 Developing our research Facsimile: (+61 3) 9345 2211 42 Patents www.wehi.edu.au www.facebook.com/WEHIresearch 43 Education www.twitter.com/WEHI_research 46 2010-11 graduates ABN 12 004 251 423 47 Seminars Acknowledgements 48 Institute awards Produced by the institute’s Community Relations department 49 Engagement Managing editor: Penny Fannin Editor: Liz Williams 51 Strategic partners Writers: Liz Williams, Vanessa Solomon and Julie Tester 52 Scientific and medical community Design and production: Simon Taplin Photography: Czesia Markiewicz and Cameron Wells 54 Public engagement 57 Engagement with schools Cover image 58 Donor and bequestor engagement Art in Science finalist 2010 Vessel webs 59 Sustainability Dr Leigh Coultas, Cancer and Haematology division 60 The Board This image shows the delicate intricacy in the developing eye of a transient population of web-like blood vessels.
    [Show full text]
  • Survey of Commercial Outcomes from Public Research (Scopr) 2019 Report
    techtransfer.org.au SURVEY OF COMMERCIAL OUTCOMES FROM PUBLIC RESEARCH (SCOPR) 2019 REPORT Survey and report delivered by FOREWORD There is an ever-present imperative to capture the commercial value of our research endeavour for our future wellbeing. To do so strategically, decision makers from laboratory, institutional and government levels need insights into how the research sector is currently engaging with industry to transfer knowledge and innovation, and thereby deliver benefits to our society from the fruits of our research. For many years in Australia there has been a focus on improving innovation metrics, thus I am delighted to acknowledge the initiative of gemaker and Knowledge Commercialisation Australasia (KCA) in producing the inaugural Survey of Commercial Outcomes from Public Research (SCOPR). The SCOPR takes its lead from the National Survey of Research Commercialisation (NSRC) produced since 2000 by the Department of Industry, Science, Energy and Resources. To avoid duplication, the Department has decided to cease the NSRC and will work with KCA to share knowledge, and access data collected by SCOPR. As we face the COVID-19 pandemic, effective knowledge transfer is more important than ever, so I hope that this report will spur our research institutions to even greater achievements. Realising effective knowledge transfer will depend on having skilled commercialisation professionals who can help researchers turn great ideas into beneficial products and services. I applaud KCA’s support for technology transfer professionals
    [Show full text]